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Responsive pentablock copolymers for siRNA delivery
Abstract
In this study, temperature and pH responsive cationic and amphiphilic pentablock copolymers, which consist
of the temperature responsive triblock Pluronic F127 sandwiched between pH responsive PDEAEM
(poly(2-diethylaminoethyl methacrylate)) end blocks, were used for the first time in the development of
polyplex and gold nanoparticle (AuNP) based multicomponent siRNA delivery systems (MCSs).
Copolymers in both systems protected siRNA from external effects, provided cell entry and endosomal
escape. The thermoreversible micellization of the hydrophobic PPO block facilitated the cellular entry while
the PDEAEM blocks enhanced the endosomal escape through protonated tertiary amine groups by pH
buffering. The synergistic advantages of the different blocks showed an enhanced effect in the MCSs due to
attachment and surface configuration reasons. The siRNA transfection efficiency of MCSs against luciferase
expressing SKOV3 cells was 15% higher than both the polyplexes alone and the commercial siRNA
transfection agent Lipofectamine RNAiMax at the same applied dose, without any toxicity. The results
indicated that the multicomponent systems based on the responsive cationic pentablock copolymers and gold
nanoparticles have promising potential as an efficient siRNA delivery vector for future applications.
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Responsive pentablock copolymers for siRNA
delivery†
Metin Uz,ab Surya K. Mallapragadab and Sacide Alsoy Altinkaya*a
In this study, temperature and pH responsive cationic and amphiphilic pentablock copolymers, which
consist of the temperature responsive triblock Pluronic F127 sandwiched between pH responsive
PDEAEM (poly(2-diethylaminoethyl methacrylate)) end blocks, were used for the ﬁrst time in the
development of polyplex and gold nanoparticle (AuNP) based multicomponent siRNA delivery systems
(MCSs). Copolymers in both systems protected siRNA from external eﬀects, provided cell entry and
endosomal escape. The thermoreversible micellization of the hydrophobic PPO block facilitated the
cellular entry while the PDEAEM blocks enhanced the endosomal escape through protonated tertiary
amine groups by pH buﬀering. The synergistic advantages of the diﬀerent blocks showed an enhanced
eﬀect in the MCSs due to attachment and surface conﬁguration reasons. The siRNA transfection
eﬃciency of MCSs against luciferase expressing SKOV3 cells was 15% higher than both the polyplexes
alone and the commercial siRNA transfection agent Lipofectamine RNAiMax at the same applied dose,
without any toxicity. The results indicated that the multicomponent systems based on the responsive
cationic pentablock copolymers and gold nanoparticles have promising potential as an eﬃcient siRNA
delivery vector for future applications.
1 Introduction
The application of small interfering RNA (siRNA) has shown
great potential for cancer treatment. Over the last decade,
progress in material science and nanotechnology has led to the
development of eﬃcient siRNA delivery systems, proposing new
approaches to overcome the major challenges and limitations
of siRNA delivery.1–3 These challenges include siRNA
condensation/attachment to the carrier material, its protection
from external eﬀects (such as, degradation by RNase enzymes),
stability, cellular entry, endosomal escape and siRNA trans-
fection eﬃciencies.4–6 In the literature, diﬀerent siRNA delivery
systems have been developed based on diﬀerent materials such
as polymers, lipids, peptides and inorganic nanoparticles.7–12
A lot of work has focused on siRNA delivery using polyplex
systems that take advantage of the direct electrostatic interac-
tions between siRNA and cationic polymers. However, a general
problem in such systems is the poor siRNA release and activity
in the cytoplasm due to strong electrostatic interactions
resulting from the excess cationic charge of polymers.13–18
Because of this obstacle, high doses of polyplexes are required
to achieve eﬃcient siRNA activity, and this brings about the use
of excessive polymer amounts which may cause potential toxic
eﬀects.15,19–21 As another hurdle, the studies have also indicated
that some of the siRNA/polymer polyplex systems are not stable
against serum protein-mediated aggregation.13,16,17,21–27 In order
to overcome these drawbacks, diﬀerent types of responsive
block copolymers have been developed to form polyplex siRNA
delivery systems. The advantage of these polymers stems from
the possibility of changing the balance between the blocks with
diﬀerent features, such as electrostatic charge, hydrophilicity,
pH and temperature responsiveness, that allows tuning of
cytotoxicity, siRNA condensation, cellular uptake, endosomal
escape and siRNA transfection eﬃciency.24,28–36
While synthetic and natural polymers have been investigated
as siRNA carriers, recent studies have focused on the applica-
tion of gold nanoparticles (AuNPs).15,19,37–40 Gold colloids can be
used for therapeutic, imaging and diagnostic purposes due to
their bio-inertness, biocompatibility, easy synthesis and surface
functionalization.41,42 In terms of siRNA delivery applications,
AuNPs were mainly used as the core of multicomponent siRNA
delivery systems (MCS), on which the subsequent system
components (such as, siRNA, polymers, peptides etc.) can be
attached easily either with chemical bonds or electrostatic
interactions. In literature, siRNA has been mostly attached on
the AuNP surfaces through disulde bonds, which can be
cleaved by glutathione in cytoplasm, in order to facilitate its
release and enhance its activity.10,19,43 However, since these
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systems with just siRNA around a AuNP core lack the ability of
eﬃciently protecting the siRNA from external eﬀects and
enabling cellular uptake, endosomal escape and siRNA trans-
fection, a functional outer layer (i.e. polymer, liposome, peptide
etc.) surrounding the siRNA coated AuNPs through electrostatic
interactions or chemical bonds was accompanied.15,19 There-
fore, the recent focus has been on the construction of AuNP
based multicomponent siRNA delivery systems, along with the
use of the cationic functional polymers.15,39,40,44–46
In this work, stimuli responsive pentablock copolymer
(PDEAEM–Pluronic F127–PDEAEM) composed of temperature
responsive Pluronic F127 (poly(ethyleneoxide)-block-poly-
(propyleneoxide)-block-poly(ethyleneoxide) (PEO-b-PPO-b-PEO))
and pH responsive cationic PDEAEM poly(2-diethylaminoethyl
methacrylate) blocks was used for the rst time in the
construction of polyplex and multicomponent siRNA delivery
systems. In our previous studies, this copolymer has been
demonstrated as an eﬃcient DNA or vaccine carrier in the form
of polyplex system,47–50 but its potential as a siRNA delivery
agent in both polyplex andmulticomponent systems has not yet
been investigated. Due to apparent diﬀerences between siRNA
and DNA in terms of size, stability of the formed nucleic acid
complexes, and the location and mechanism of action, the
same pentablock copolymer eﬃcient in DNA delivery may show
diﬀerent behavior in siRNA delivery.6,51,52 Therefore, it is critical
to investigate the eligibility of this copolymer in siRNA delivery
systems.
The pentablock copolymers were designed and chosen for the
polyplex and multicomponent siRNA delivery systems over the
use of cationic polymers, such as polyethylene imine (PEI),
because of several advantages. The central triblock Pluronic F127
in the pentablock copolymer contributes to the temperature
responsive micellization and has been reported to be able to
promote cellular entry while the pH responsive cationic end
blocks, PDEAEM, facilitate nucleic acid condensation and
endosomal escape.47,48,52–54 Thermoreversible micellization
occurs in aqueous solutions because of the lower critical solu-
tion temperature (LCST: 8 C) of hydrophobic poly(propylene-
oxide) (PPO) block in the middle of Pluronic F127. The presence
of hydrophobic PPO chains provide copolymers with the unique
ability to be incorporated into cell membranes by enhancing cell
interactions and increase translocation of delivery systems into
the cells, with minimal damage to the cell membrane integ-
rity.53–55 The end blocks, poly(diethylaminoethyl methacrylate)
(PDEAEM), are the essential functional cationic segments (pKa
7.3) to complex with siRNA and to provide pH buﬀering capacity
at low pH of the endosome with their protonatable tertiary
amine groups that aids in the release of entrapped delivery
systems from the acidic endosomal vesicles through the proton
sponge mechanism.49,55,56 Unlike with the use of cationic poly-
mers such as PEI, the cytotoxicity of these pentablock copoly-
mers can be tuned by changing the balance between the cationic
and non-ionic blocks.57 Herein, we present a polyplex system
obtained by direct electrostatic interactions between siRNA and
pentablock copolymers. We also present a multicomponent
system (MCS), developed by the subsequent deposition of siRNA
and pentablock copolymers on AuNP surface through cleavable
disulde bonds (to enhance siRNA release) and through the
electrostatic interactions (to protect siRNA, enhance cellular
uptake, endosomal escape and siRNA activity), respectively
(Scheme 1A and B). Both delivery systems were characterized to
verify the formation of complexes, the adsorption of each layer
on the AuNPs, and the siRNA loading. In addition, their
performances in terms of siRNA protection and stability, toxicity,
cellular uptake, endosomal escape and transfection eﬃciencies
against luciferase expressing SKOV3 cells were evaluated and
compared.
2 Experimental
2.1 Reagents
Hydrogen tetrachloroaurate(III) trihydrate (99.9%) and sodium
citrate used in the preparation of gold nanoparticles were
purchased from Sigma-Aldrich. Thiol and amine end group-
modied PEG (SH-PEG-NH2: MW 1000) used for gold nano-
particles surface modication was purchased from Creative PEG
works. SPDP (N-succinimidyl-3-(2-pyridyldithio)-propionate)
cross linker was obtained from Fisher Thermo Scientic. The
SKOV3 cell line was purchased from Creative Biogenes. The cell
culture media, Dulbecco's Modied Eagle Medium (DMEM) and
cell culture media additives, fetal bovine serum (FBS), MEM non-
essential amino acids (NEAA) and penicillin streptomycin were
obtained from Invitrogen. The uorescence dyes, Lysotracker
Red and Hoechst, used in staining lysosome and nucleus
respectively, were obtained from Invitrogen. Cell titer96 and
Luciferase assay kits were obtained from Promega. The Quant-
iT™ Ribogreen® siRNA detection kit was purchased from Invi-
trogen. The thiol modied siRNA sequence (siRNA: sense: 50 HS-
GAUUAUGUCCGGUUAUGUA-UU 30; antisense: 50 UACAUAACCG
GACAUAAUC-UU 30) was obtained from IDT-DNA. All the buﬀers
were prepared by using RNase free ultrapure water according to
standard laboratory procedures.
2.2 Preparation of polyplexes
The pentablock copolymers used in this study, PDEAEM–
Pluronic F127–PDEAEM, were synthesized by atom transfer
radical polymerization (ATRP) as explained elsewhere48 and
characterized as described in ESI.† siRNA/Polymer polyplexes
at various N/P ratios (N/P: molar ratios of nitrogens (N) in the
Scheme 1 (A) PDEAEM/Pluronic F127/PDEAEM–siRNA polyplexes.
(B) AuNP–PEG–siRNA–PDEAEM/Pluronic F127/PDEAEM multicom-
ponent delivery system (MCS).
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pentablock copolymer to phosphates (P) in siRNA: 100, 75, 50,
25, 10, 5, 2.5) were prepared by adding appropriate quantities
of pentablock copolymer solution in 1 Hepes Buﬀer, pH 7.0
to siRNA solutions. The mixture was briey vortexed and
allowed to incubate at room temperature for 30 min to ensure
complexation.
The siRNA condensation and formation of the polyplexes
was visualized on a 2% (w/v) agarose gel containing 0.5 mg mL1
ethidium bromide (EtBr) for 30 min at 100 V in a 1 TAE buﬀer
solution (40 mM TrisHCl, 1% (v/v) acetic acid, and 1mM EDTA).
The samples were loaded in wells and electrophoretic mobility
of the polyplexes was visualized and image capture were
accomplished using a UV-trans illuminator. In addition, the
changes in size and zeta potential of the prepared polyplexes in
serum-containing cell culture media were observed with respect
to time by dynamic light scattering (DLS).
2.3 Preparation of the multicomponent system
2.3.1 Preparation of gold nanoparticles. The 13 nm gold
nanoparticles were prepared using the citrate reduction
method.58 In a typical experiment, 2 mL of 38.8 mM sodium
citrate was quickly injected into 20 mL of 1 mM boiling HAuCl4
solution under vigorous stirring. The heating was continued for
10 min. Then, the solution was kept stirred for another 15 min
without heating.
2.3.2 PEG coating. Thiol-PEG-amine (HS-PEG-NH2) (1
mg mL1) was added to the prepared 13 nm AuNP solution to
coat the AuNP surface. The reaction was carried out under
continuous stirring in the dark at room temperature during
24 h. The complex formed was centrifuged under 20 000 rpm for
15 min and washed with PBS to eliminate weakly bound PEGs.
2.3.3 SPDP modication. The PEG coated AuNPs were
further modied by SPDP (N-succinimidyl-3-(2-pyridyldithio)-
propionate), which is an amine and sulydryl reactive hetero-
bifunctional cross linker, in order to facilitate the attachment of
siRNA through thiol-disulde exchange reaction. SPDP solution
(1 mM, 10% DMSO in PBS–EDTA) was mixed with AuNP–PEG
solution (10 nM, in PBS–EDTA) and incubated at room
temperature under mild stirring during 6 h. At the end of 6 h,
the modied particles were centrifuged, washed with PBS for 4
times in order to remove excess amount of unreacted SPDP and
characterized through UV-vis spectrophotometer and DLS.
2.3.4 siRNA attachment. The precipitated SPDP-modied
AuNPs were resuspended in borate buﬀer containing 15 mM
SH-siRNA. The mixture was incubated at room temperature for
48 h under continuous shaking. At the end of the incubation,
the siRNA loaded AuNPs were precipitated by centrifugation
and washed with PBS three times in order to remove excess
siRNA. The resuspended nanoparticles were treated with 0.05 M
DTT in order to break the disulde bonds between the siRNA
and SPDP cross linker and the free siRNA was detected by
Quant-iT™ RiboGreen siRNA detection kit by following the
manufacturer's protocol. In order to verify the conjugation, the
siRNA loaded samples were run on an agarose gel following the
same procedure mentioned in Section 2.2.
2.3.5 Polymer coating. siRNA attached to the AuNPs was
complexed with pentablock copolymers through electrostatic
interactions. The molar ratios of AuNP/pentablock copolymers
were varied as 1/10, 1/50 and 1/100. The polymer solution in
1 Hepes buﬀer (3 mg mL1) was added to the 20 nM siRNA–
AuNPMCS and incubated 20min at room temperature to ensure
the complexation. Then, the samples were run on an agarose gel
to demonstrate the complexation. Moreover, the RNase and
serum stability of the MCS was tested by gel electrophoresis by
following the same procedure mentioned in Section 2.2.
2.4 Characterization of multicomponent systems
The changes in size, size distribution and zeta potential values
of prepared MCSs aer each modication were determined by
using Dynamic Light Scattering (DLS). In addition, the stability
of the MSCs in terms of size and zeta potential in serum con-
taining cell culture media were also evaluated with respect to
time by DLS. Bare and modied AuNPs were characterized by
observing the shi in the unique surface plasma resonance of
AuNPs around 520 nm in the UV-vis spectra upon the modi-
cation. The PEG modication of AuNPs was veried by trans-
mission electron microscope (TEM) (Tecnai G2 20 S-TWIN).
Samples were prepared by dipping a carbon-coated copper grid
in 20 mL colloidal solution of naked or modied AuNPs. For
visualizing the PEG layer, 10 mL of AuNPs solution was dropped
on TEM grid and waited for 3 min, then excess solution was
taken back. 2% (v/v) uranyl acetate solution was used for
negative staining. Excess negative solution on the grid was
removed using a lter paper and residual solution was air-dried.
2.5 Performance evaluation of developed systems
2.5.1 RNase and serum protein stability of the systems.
The protective eﬀect and stability of the polyplex and multi-
component systems against RNase and serum proteins were
tested by gel electrophoresis. The developed systems (polyplexes
and MCSs) were incubated with 0.25% RNase and 50% serum
containing HEPES buﬀer at 37 C for 6 h. Then, the samples
were loaded in the agarose gel electrophoresis wells and run
under the same conditions mentioned in Section 2.2.
2.5.2 Cell culture. The luciferase-expressing SKOV3 cells
(Creative Biogene CSC-RR0061) were grown in high glucose
Dulbecco's Modied Eagles Medium (DMEM, Invitrogen) sup-
plemented with 10% (v/v) fetal bovine serum (FBS, heat inacti-
vated, GIBCO), 0.1 mM MEM Non-Essential Amino Acids
(NEAA), 2 mM L-glutamine and 1% Pen-Strep at 37 C under a
humidied atmosphere containing 5% CO2. Cells were sub-
cultured approximately every 2–3 days.
2.5.3 Cellular uptake and accumulation. The cellular
uptake of siRNA/Polymer polyplexes was evaluated by ow
cytometry analysis. For this purpose, the previously synthesized
pentablock copolymers (Polymer A) were modied by alkyne
attached uorescence dye AlexaFluor 488 through the azide–
alkyne click reaction (see ESI†). siRNA/Polymer polyplexes were
prepared using the dye-attached polymers by following the
same procedure mentioned in Section 2.2.
This journal is © The Royal Society of Chemistry 2015 RSC Adv., 2015, 5, 43515–43527 | 43517
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Before the ow cytometry analysis, the cells were seeded
(2  105 cell per well) and grown to 80% conuency. Then, the
siRNA/Polymer polyplexes with diﬀerent N/P ratios, prepared by
using AlexaFluor 488 uorescence dye attached Polymer A, were
added to the cells. Aer 24 h of incubation at 37 C under 5%
CO2 atmosphere, the cells were harvested and washed with PBS
and kept cold until the analysis. Then, the uorescence inten-
sity of the polyplexes within the cells were measured by ow
cytometer (BD Biosciences Facs Canto).
The cellular uptake of the MCS was evaluated by inductively
coupled plasma mass spectrometry (ICP-MS) measurements.
The SKOV3 cells with a concentration of 1  105 cells per well
were plated in 6-well plates and incubated 24 h at 37 C in a 5%
CO2 atmosphere. Then, the MCS with an AuNP/Polymer ratio of
1/10, 1/50, 1/100 were administered and further incubated for
24 h under same conditions. Aer incubation, the cells were
washed 3 times with PBS in order to remove the MCS remaining
on the outer cell membrane, harvested using Trypsin–EDTA and
dispersed in 2 mL of cell culture medium. The cells were
collected by centrifugation (1000 rpm, 5 min) and the cell pellet
was dispersed in 0.5 mL of concentrated HNO3 at 70 C for 4 h.
At the end of serial dilutions, the amount of gold in the cells was
analyzed by ICP-MS. The number of AuNPs in cells was calcu-
lated as described in ESI.†
2.5.4 Confocal microscopy. Both of the developed systems
with dye-attached polymers were visualized through confocal
microscopy. The SKOV3 cells (2 mL) were plated at a density of
2  105 cells per well in cell culture Petri dishes and incubated
24 h at 37 C in a 5% CO2 atmosphere. Then, the polyplexes
and MCS prepared using the dye-attached polymers were
administered to the wells at a concentration of 2 nM and
further incubated with cells during 24 h under same condi-
tions. For live cell imaging, rst, the growth medium was
removed and cells were washed 3 times with PBS. Then, 2 mL
of serum free medium was added to wells and 250 nM Lyso-
tracker Red was added. The Petri dishes were incubated
30 min at 37 C in a 5% CO2 atmosphere. For the nucleus
staining with Hoechst, the growth medium with Lysotracker
Red was removed and washed 3 times with PBS. Following
this, 2 mL of serum free medium was added to Petri and 1 mM
of Hoechst dye was applied. The dye applied Petri dish was
incubated 30 min at 37 C in a 5% CO2 atmosphere for nucleus
staining. At the end, the cells were washed again and analyzed
through confocal microscopy.
2.5.5 Cytotoxicity tests. Cell Titer 96 assay was used to
determine the in vitro cytotoxicity of the systems. The SKOV3
cells (100 mL) were plated at a density of 2  104 cells per well in
separate 96-well plates and incubated for 24 h at 37 C in a 5%
CO2 atmosphere. The polyplexes and MCS were administered to
the wells in various concentrations and further incubated for
24 h under same conditions. Finally, the measurements were
conducted by following the manufacturer's procedure. 15 mL of
the dye solution was added to each well and the plate was
incubated at 37 C for up to 4 hours in a humidied, 5% CO2
atmosphere. Next, 100 mL of the solubilization solution was
added to each well and plate was allowed to stand in the dark
overnight at room temperature to completely solubilize the
formazan crystals. The absorbance at 570 nm wavelength was
recorded using a 96-well plate reader.
2.5.6 Luciferase activity test. The transfection eﬃciency of
the systems was evaluated using the Promega luciferase assay
system protocol. For this purpose, the SKOV3 cells (100 mL) were
plated at a density of 2  104 cells per well in separate 96-well
plates and incubated 24 h at 37 C in a 5% CO2 atmosphere.
Then, the polyplexes and MCS were administered to the wells at
various doses and further incubated for 24 h under same
conditions. Following incubation, the growth medium was
removed and the cells were washed with PBS. 20 mL of 1 lysis
buﬀer was added to the cells and the plate, containing 20 mL of
cell lysate per well, was placed into the luminometer (Veritas
Microplate Luminometer) Upon the 100 mL of Luciferase Assay
Reagent injection per well, immediate readings were recorded.
The luciferase suppression eﬃciencies of the developed systems
were compared with the commercial lipofectamine RNAiMax
siRNA transfection reagent as control. The commercial
siRNA/RNAiMax complexes were prepared and applied by
following the manufacturer's protocol. The luciferase suppres-
sion eﬃciency of the commercial product was evaluated as
mentioned above.
2.6 Statistical analysis
Throughout this study, the signicant diﬀerences between the
groups were evaluated using ANOVA analysis by Tukey's method
with 95% condence interval. The results are presented as
average  standard deviation calculated from at least three
independent experiments.
3 Results and discussion
The properties of the synthesized pentablock copolymers used
to form polyplex and MCSs for siRNA delivery are summarized
in Table 1 and illustrated in Fig. S1 through S4 in ESI.† The
performances of Polymer A and Polymer C (Table 1) with
diﬀerent molecular weights were evaluated for both of the
systems against SKOV3 cells in terms of siRNA protection,
cellular entry, endosomal escape and siRNA transfection
eﬃciency.
3.1 siRNA/polymer polyplex system
The siRNA/polymer polyplex system formed mainly by electro-
static interactions between negatively charged siRNA and posi-
tively charged polymers is illustrated in Scheme 1A. The
polyplex formation was determined through gel retardation as
shown in Fig. 1A. Complete complexation of siRNA with Poly-
mers A and C was observed at N/P ratios of 50, 75 and 100. On
the other hand, the decrease in the polymer amount resulted in
incomplete condensation of siRNA as demonstrated by similar
mobilities of the naked siRNA with that of the siRNA condensed
on the polymers when the N/P ratio was 1.25 (Fig. 1A.). Fig. 1
also indicated that there was no signicant diﬀerences in the
amount of condensed siRNA for the diﬀerent polymer types.
Preliminary screening tests for luciferase expression activity
in SKOV3 cells indicated that the polyplexes prepared by
43518 | RSC Adv., 2015, 5, 43515–43527 This journal is © The Royal Society of Chemistry 2015
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Polymers A and C with N/P ratios of 75 and 100 caused a
signicant decrease in luciferase expression at applied doses.
However, the toxicity tests showed that the actual reason for the
decrease in the luciferase expression was due to severe toxic
eﬀect of the applied dose (Fig. S5 in ESI†). On the basis of these
results, we decided to use N/P ratios of 10, 25 and 50, at which
the siRNA activity can be observed without signicant toxicity. It
was noted that the longer PDEAEM chains of Polymer C with
higher molecular weight (36 000) than Polymer A caused
signicant toxic eﬀects (Fig. S6†), which resulted from its
excessive cationic charge, biasing the luciferase suppression
results (Fig. S7†) for almost all doses and N/P ratios. This situ-
ation makes it diﬃcult to ascertain the pure siRNA delivery
eﬃciency of the system with Polymer C, and makes it less
feasible for use in biomedical applications. Therefore, all cyto-
toxicity and luciferase activity results obtained by Polymer C are
included in ESI† and the systems with Polymer A are discussed
here.
The stabilities of selected polyplexes against RNase enzymes
and serum proteins degradation have been evaluated by gel
electrophoresis, size and zeta potential measurements. Poly-
plexes did not show a signicant sign of siRNA degradation,
polyplex disassembly or dissociation in the presence of RNase
or serum proteins as illustrated in Fig. 1B. In addition, it was
noted that the zeta potential and size of polyplexes incubated in
serum containing cell culture media for 72 h did not change
signicantly, except for the particular polyplex with N/P ratio of
25 showing slight decrease in zeta potential upon 72 h of
incubation (Fig. S8 and S9,† respectively). The size and zeta
potential stabilities of the polyplexes was attributed to the
hydrophilic PEO chains of Pluronic F127, which plays a vital
role in providing shielding and stealth eﬀects, therefore, pre-
venting the aggregation of particles.55 On the other hand, the
stabilities of the polyplexes in RNase and serum containing
environment could result from both the strong electrostatic
condensation/encapsulation of siRNA in the polyplex matrix
and shielding eﬀect of Pluronic F127 block, minimizing its
interactions with external eﬀects.13–15,17
Besides providing protection and stability against external
eﬀects, a proper siRNA delivery system should also facilitate
cellular entry and endosomal escape in order to enable eﬃcient
transfection. The cellular accumulation of the polyplexes
prepared by attaching a uorescent dye to Polymer A was
investigated through ow cytometry. The results indicated that
the increase in N/P ratio induced the cellular accumulation of
the polyplexes at the end of 24 h of incubation (Fig. 2A). In
addition, it was noted that the internalization of the polyplexes
prepared at N/P ratio of 50 increased with time as shown in
Fig. 2B. The increased amount of polymer used in the polyplex
formulations brings about an augmentation in cationic charge
(Fig. S8,† 24 h incubation data), inducing cell membrane
interactions, as well as the presence of more hydrophobic PPO
groups, capable of promoting cell membrane internalization
through thermoreversible micellization and hydrophobic
interactions.55
It is known that aer an eﬃcient entry into the cells, the
nanocarrier should facilitate escape from the endo-lysosomal
pathway in order to prevent degradation of siRNA by many
enzymes in the structure of the cell.59 The intracellular distri-
bution of the prepared polyplex systems was investigated by
confocal microscopy. Fig. 3 shows that most of the polyplexes
were captured by lysosomes preventing their accumulation in
the cytoplasm. The quantitative analysis indicated that only
58.2% of polyplexes managed to escape from endosome while
the rest were captured. Almost 50% entrapment of the poly-
plexes could be potentially attributed to the location and
number of protonatable free tertiary amine groups in the
polyplexes. It is anticipated that the bulk complexation of
polymers with siRNA, possibly caused embedding of the
Table 1 Molecular weight and degree of polymerization (DP) data for the Pluronic F127 and PDEAEM-based pentablock copolymers synthesized
by ATRP
GPC NMR
Mw (g mol
1) Mn (g mol
1) Mw/Mn Mn (g mol
1) DP
Pluronic F127 13 560 12 540 1.08
Pluronic F127 macroinitiator 14 810 13 150 1.12
PDEAEM–Pluronic F127–PDEAEM
(Polymer A)
32 240 26 650 1.2 15 650 3
PDEAEM–Pluronic F127–PDEAEM
(Polymer C)
72 450 36 050 2.01 18 522 1.85
Fig. 1 (A) Gel electrophoresis of siRNA/Polymer polyplexes with
Polymer A and Polymer C at various N/P ratios: 1.25, 2.5, 5, 7.5, 10, 25,
50, 75, 100. Control: naked siRNA. (B) RNase and serum stability of the
polyplexes prepared by Polymer A at N/P ratios of 10, 25 and 50.
Control: naked siRNA and RNase exposed naked siRNA and serum
exposed naked siRNA.
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responsive blocks in polyplex matrix, resulting in potential
obstruction of their responsive properties.
To evaluate the transfection eﬃciency and toxicity of the
siRNA/Polymer polyplexes prepared with Polymer A, they were
administered to the SKOV3 cells at diﬀerent doses (50, 100,
200 nM). All of the polyplexes with Polymer A were found to be
nontoxic at all applied doses except that the polyplex prepared
at N/P ratio of 50 reduced cell viability to 60% when the
applied dose was 200 nM (Fig. 4). This may stem from the use of
excess polymer amount and cationic charge for the
complexation.20,21 The zeta potential values obtained for 24 h of
incubation (Fig. S8†) indicated that the increase in N/P ratio
from 10 to 50 resulted in signicant increase in cationic charge
of the polyplexes. Even though the highest zeta potential value
was 7 mV, it seemed to be suﬃcient to show moderate toxic
eﬀect at the highest dose of 200 nM. The eﬀect of dose on the
toxicity was found to be signicant only at the highest N/P ratio
which could be due to much higher cellular uptake potential of
this polyplex than the others as shown in Fig. 2.
Luciferase activity tests indicated that almost all of the
polyplexes prepared with Polymer A showed signicantly higher
luciferase expression suppression without severe toxicity as
compared to the naked siRNA (Fig. 5). This result illustrated the
necessity of polymer usage to enhance the siRNA transfection
eﬃciency. The polyplexes formed at N/P ratios of 50 were able to
suppress more than 60% of the luciferase expression at the
maximum applied siRNA dose, 200 nM (Fig. 5). However, the
signicant toxicity observed at this dose (Fig. 4) led to the
conclusion that suppression of the luciferase expression was
not completely as a result of siRNA activity but was also due to
the toxic eﬀect of the polyplexes. Similarly, gene silencing
caused by the polymer alone (without siRNA) at the highest dose
of N/P: 50 (control groups in Fig. 5) can be attributed to toxic
eﬀect of the polymers on the cells (Fig. 4). The polyplexes
induced toxicity since the required amount of polymer to
condense 200 nM of siRNA is severely high. At lower doses, the
polymers alone (without siRNA) as control exhibited neither
signicant luciferase expression suppression nor toxicity.
Except for this particular case (N/P: 50 and 200 nM dose), for all
of the polyplexes selected, 50% decrease in luciferase expres-
sion was observed without toxicity regardless of the changes in
their dose and N/P ratio. The cellular uptake values of the pol-
yplexes varied depending on the N/P ratio (Fig. 2), however, even
for the highest uptake (N/P ratio: 50 in Fig. 2A), the most of the
complexes were observed to be entrapped in endosome (Fig. 3)
Fig. 3 Confocal images of siRNA/Polymer A polyplexes prepared at
N/P ratio of 50. Incubation time: 24 h. Green: polyplexes stained by
Alexaﬂour488, Red: lysosome stained by Lysotracker Red, Blue:
nucleus stained by Hoechst.
Fig. 4 Cell viability of siRNA/Polymer A polyplexes administered to
SKOV3 cells. N/P: 10, 25, 50. Applied siRNA dose: 200, 100, 50 nM.
Initial SKOV3 cell density: 1.5  104 cell per well. Incubation time: 24 h.
(a and b) Represent doses of siRNA/Polymer A polyplexes which
caused signiﬁcant diﬀerence in cell viability (p < 0.05) for N/P ratios of
25 and 50, respectively. (c and d) Represent the siRNA/Polymer A
polyplexes prepared at diﬀerent N/P ratios which showed signiﬁcant
diﬀerence (p < 0.05) in cell viability at doses of 200 and 100 nM,
respectively.
Fig. 2 (A) The cellular accumulation of siRNA/Polymer A polyplexes
prepared at diﬀerent N/P ratios. Incubation time: 24 h. (B) Time
dependent cellular uptake of siRNA/Polymer A polyplexes (N/P ratio:
50). * Represents statistical signiﬁcant diﬀerence (p < 0.05).
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which consequently decreased their transfection eﬃciency. The
possible strong electrostatic complexation of siRNA with poly-
mers may provide good siRNA protection, however, it may also
prevent eﬃcient siRNA release and transfection eﬃciency in
cytoplasm. Therefore, due to its restricted release, the amount
of siRNA required for suﬃcient gene silencing eﬀect is usually
high. This brings about the use of high amount of polymer for a
complete condensation of siRNA, which present severe toxicity
problems for polyplex systems. Though it is not a direct
comparison, the 50% decrease in luciferase expression may
seem to be relatively low as compared to some ndings in the
literature obtained with diﬀerent siRNA sequences and carrier
materials against diﬀerent cell lines.15,19,37,45 Considering this, a
direct comparison of the selected polyplexes with a commercial
product (Lipofectamine RNAiMax transfection reagent) under
same circumstances would give a better idea about the perfor-
mances of the developed systems. The results in Fig. 5 illus-
trated that all of the selected polyplexes showed the same
luciferase expression suppression (50%) as the commercial
RNAiMax transfection reagent. Overall, these results suggest
that the complexes with Polymer A may be reasonable candi-
dates for siRNA delivery, but without signicant advantages
over existing systems.
3.2 The multicomponent siRNA delivery system
To improve the performance of the pentablock copolymer-
based systems, a multicomponent siRNA delivery system
based on AuNPs and pentablock copolymers (Scheme 1B) was
developed. The rst step in the synthesis was modication of
the AuNPs with heterobifunctional PEG to increase stability
and facilitate the attachment of subsequent layers through
cleavable disulde bonds. In addition to providing conjuga-
tion sites for further surface modications, the PEG layer on
AuNPs also acted as a buﬀer layer avoiding the possible reac-
tions between the bare AuNP surface and disulde bonds,
through which the siRNA attached to the PEG layer, since such
interactions have possibility to induce siRNA release.19 The
PEG coating resulted in an increase in the cumulative size of
the AuNPs from 12.5 to 18 nm as shown by DLS data rep-
resented in Table 2. Despite the increase in size, there was not
a signicant increase in polydispersity index (PDI) values. The
PEG layer coated on the AuNPs was also observed in TEM
images (Fig. S10†). The thickness of the PEG layer was evalu-
ated as 6 nm from both DLS data (Table 2) and TEM images.
Another indication of successful PEG coating was the change
in the zeta potential values. Upon PEG attachment, the nega-
tively charged surface of the bare AuNPs (33.3 mV) became
Fig. 5 Luciferase expression suppression of prepared siRNA/Polymer A polyplexes. N/P: 10, 25, 50. Applied siRNA dose: 200, 100, 50 nM. Initial
SKOV3 cell density: 1.5  104 cell per well. Controls: amount of Polymer A required to form polyplexes possessing N/P ratio 10, 25, 50 (without
siRNA), commercial Lipofectamine RNAiMax siRNA transfection reagent, naked siRNA, SKOV3 control cell. Incubation time: 24 h. For N/P ratio of
50, letters a and b on the bars represent doses of siRNA/Polymer A polyplexes or Polymer A alone, respectively, which caused signiﬁcant
diﬀerence in luciferase expression suppression (p < 0.05). Letter c represents the signiﬁcant diﬀerence between siRNA/Polymer A polyplex and
commercial Lipofectamine RNAiMax transfection reagent in terms of luciferase expression suppression (p < 0.05). *Compared to siRNA/Polymer
A polyplexes, Polymer A alone showed signiﬁcantly lower luciferase expression suppression (p < 0.05) at all N/P ratios and doses applied. ** The
luciferase expression suppression values obtained with 200 nM naked siRNA or SKOV3 cells were also found signiﬁcantly lower (p < 0.05) than
the suppression provided by 200 nM siRNA/Polymer A polyplex prepared at all N/P ratios.
Table 2 Size, zeta potential and polydispersity index (PDI) values of bare and modiﬁed AuNPs
AuNP AuNP–PEG AuNP–PEG–SPDP AuNP–PEG–siRNA AuNP–PEG–siRNA–Polymer
Size (nm) 12.46  0.66 18.09  0.64 20.35  0.91 31.77  0.11 168.93  3.48
PDI 0.23 0.25 0.24 0.25 0.57
Zeta potential (mV) 33.3  0.98 20.23  1.18 3.88  1.49 2.64  0.67 6.98  0.90
This journal is © The Royal Society of Chemistry 2015 RSC Adv., 2015, 5, 43515–43527 | 43521
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positively charged (+20.2 mV) due to the presence of –NH2
groups at the open end of the PEG (Table 2). The change in the
UV-vis spectra of the MCS can also give clues about the success
of the surface modications (Fig. 6). Maximum absorption in
the spectra for the 13 nm sized bare AuNPs is observed at 520
nm and a red shi from 520 to 525 nm without severe
broadening in the spectra indicated successful PEG coating.
In order to introduce disulde bonds on the particles, the
PEG modication was further followed by the SPDP attachment
to the AuNP–PEG MCS through the amide bond. The SPDP
conjugation was veried by the red shi indicating a movement
from 525 (AuNP–PEG) to 527 nm (AuNP–PEG–SPDP) on the
absorption maximum in the UV-vis spectra (Fig. 6). Moreover,
due to the successful SPDP attachment, there was a decrease in
the surface charge from +20.2 to +3.88 mV (Table 2), however,
the cumulative size of AuNP–PEG MCS did not increase signif-
icantly since the size of the SPDP cross linker is too small.
The deprotected thiol modied siRNA (HS-siRNA) was
attached to the AuNP–PEG–SPDP MCS through the thiol-
disulde exchange reaction. The zeta potential of the MCS
turned from positive (+3.88 mV) to slightly negative (2.64 mV)
and size increased from20 to32 nm upon attachment of the
siRNA (Table 2). In addition, the maximum absorbance wave-
length shied from 527 (AuNP–PEG–SPDP) to 534 nm with
signicant broadening in the spectra (Fig. 6). The siRNA loaded
MCS along with naked siRNA were run in gel electrophoresis. As
shown in Fig. 7, the MCS were retarded compared to the naked
siRNA and these results provided another evidence of siRNA
attachment to the AuNPs.
The amount of siRNA loaded onto the nanoparticles was
determined to be 560 nM while the maximum theoretical
loading to achieve a complete surface coverage was calculated
as 880 nM (see ESI†). The last step in the synthesis of multi-
component system was to coat siRNA loaded AuNPs with pen-
tablock copolymers through electrostatic interactions between
negatively charged siRNA and positively charged groups on the
copolymer. Table 2 shows that the polymer coating resulted in
an increase in zeta potential of the AuNP–PEG–siRNA from
2 mV to +7 mV. The change in the surface charge from
negative to positive subsequent to polymer coating is due to the
presence of cationic groups of the polymer. In addition, the size
of the MCS increased from 31 to 169 nm (Table 2) and a
signicant shi in the maximum absorbance wavelength and
broadening in the spectra (Fig. 6) were observed upon the
assembly of polymer layer on the surface.
The RNase and serum protein stabilities of the MCS were
tested through gel retardation. Fig. 7 illustrated that the siRNA
loaded MCS with polymer coating on the outer surface showed
good siRNA protection against RNAse and serum proteins, since
the intensity of these MCS were almost the same with the naked
siRNA used as control. This result conrms that the MCS did
not show any dissociation in the presence of serum proteins or
RNases by protecting loaded siRNA. The stabilities of the
multicomponent systems were also observed through the
changes in the size and zeta potential values. The results indi-
cated that the zeta potential of MCSs did not change signi-
cantly aer 72 h of incubation in serum containing cell culture
media for the AuNP/Polymer ratios of 1/50 and 1/100 while
slight increase in size from 160 to 170 nm and slight
decrease in zeta potential from 2 mV to 0.5 mV were
observed for the MCS prepared with AuNP/Polymer ratios of
1/100 and 1/10, respectively (Fig. S8 and S9†). The amount of
polymer used to coat the surface of AuNP–PEG–siRNA was
signicantly lower than the one required to make polyplexes. It
Fig. 6 UV-vis spectra of AuNP, PEG modiﬁed AuNP, SPDP and siRNA modiﬁed AuNP–PEG MCS.
Fig. 7 Agarose gel electrophoresis retardation of AuNP–siRNA MCS
(without polymer) and naked siRNA. RNase and serum protein stabil-
ities of the MCS prepared with Polymer A. AuNP/Polymer ratios: 1/10,
1/50 and 1/100.
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can be claimed that the zeta potential and size stability of MCSs
might depend on how the polymers attach to the AuNP–PEG–
siRNA surface. Contrary to the case of polyplexes, the polymers
are expected to electrostatically attach to the siRNA on the AuNP
only from the surface rather than bulk complexation. Therefore,
most of the positively charged PDEAEM end blocks would tend
to attack siRNA while leaving the middle Pluronic F127 block
free close to the outer surface. The hydrophilic PEO blocks of
Pluronic F127 on the outer surface enhances the colloidal
stability of the system in serum containing cell culture media by
providing shielding eﬀect.55 As a result of this shielding eﬀect, it
can be said that the MCSs, prepared with Polymer A, possessed
relatively better size and zeta potential stability at high AuNP/
Polymer ratios (1/50 and 1/100) compared to the polyplexes
(Fig. S8 and S9†).
The quantication of MCSs uptaken by the cells was per-
formed by ICP-MS. Fig. 8A shows that the cellular accumulation
of MCS signicantly increased as the AuNP/Polymer ratio
changed from 1/10 to 1/100 at the end of 24 h incubation. With
the increased polymer amount, more hydrophobic PPO blocks in
Pluronic F127 and more free positively charged PDEAEM blocks
on the surface are present and they enhance the cellular entry
through hydrophobic and electrostatic interactions, respectively.
The time dependent cellular uptake of MCSs prepared with
AuNP/Polymer ratio of 1/100 was also investigated (Fig. 8B) indi-
cating that the internalized amount of MCSs increased with time.
Fig. 9 illustrates that the uptaken MCSs were able to escape
from endosome and distributed in cytoplasm. Compared to the
polyplexes alone shown in Fig. 3, MCSs seemed to provide a
better endosomal escape (Fig. 9). The quantitative analysis
indicated that 75.6% of the MCSs escaped from endosome
while only 58.2% of polyplexes managed to provide endosomal
escape. It is anticipated that this is presumably due to the
attachment of polymer layer to the AuNP–PEG–siRNA conjugate
solely on the surface rather than bulk complexation.60 Alterna-
tively, this situation could have stemmed from the conforma-
tion of the polymer on the outer layer of MCSs.61,62 The
distribution and therefore, availability of free tertiary amine
groups on the surface of MCSs was potentially higher than in
the case of the polyplexes alone.
The transfection eﬃciency and toxicity of AuNP–siRNA–Poly-
mer MCS on the SKOV3 cell line were also evaluated. We have
previously shown that the cationic polyplexes are moderately
toxic which probably originates from their high doses, excess
cationic charge and strong interactions with the cell surface,
leading to cell membrane disruption (Fig. 4 and S6†). On the
other hand, the AuNP–siRNA–Polymer A MCS, including smaller
amounts of cationic polymers in the structure compared to
traditional polyplexes, displayed no decrease in cell viability as
shown in Fig. 10. Therefore, the developed MCSs provided
transfection eﬃciencies without any toxic damage. The results in
Fig. 11 indicated that the MCS without polymer (AuNP–siRNA)
did not display any silencing eﬀect while the polymer coated
MCSs showed comparatively signicant luciferase suppression
regardless of their dose or AuNP/Polymer ratio. This result clearly
illustrates the benet of the pentablock copolymer in providing
siRNA protection, facilitating cellular entry and endosomal
escape and nally enhancing the silencing eﬀect. In general, it
was observed that the transfection eﬃciency of the MCS
including polymer A increased with the dose but did not change
with the AuNP/Polymer ratio except for the case of AuNP/Polymer
ratio of 1/100 at the highest dose (5 nM in terms of AuNP)
(Fig. 11). In the literature it was observed that in contrast to the
case of polyplex siRNA delivery systems, multicomponent
approaches have shown the added advantage of making it
possible to achieve higher siRNA activity with lower siRNA load-
ings and lower polymer concentrations, thereby signicantly
reducing toxicity.19,37,43,63–67 Herein, we also noticed that
compared to the siRNA/Polymer polyplexes, the MCS systems
Fig. 8 (A) The number of AuNPs in SKOV3 cells measured by ICP-MS.
Incubation time: 24 h. (B) Cellular uptake of AuNP–siRNA–Polymer
MCS as a function of time. AuNP/Polymer ratio: 1/100. * Represents
statistical signiﬁcant diﬀerence (p < 0.05).
Fig. 9 Confocal images of AuNP–siRNA–Polymer A MCS prepared by
AuNP/Polymer ratio of 1/100. Incubation time: 24 h. Green: polyplexes
stained by Alexaﬂour488, Red: lysosome stained by Lysotracker Red,
Blue: nucleus stained by Hoechst.
This journal is © The Royal Society of Chemistry 2015 RSC Adv., 2015, 5, 43515–43527 | 43523
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achieved better transfection eﬃciencies at the same level of
siRNA loadings without showing severe toxicity. For instance, the
siRNA/Polymer A polyplex formed at N/P ratio of 50 with 100 nM
siRNA loadingmanaged to decrease luciferase expression by 50%
(Fig. 5) while the multicomponent system prepared with 100 nM
siRNA loading (5 nM in terms of AuNP) succeeded in providing
65% luciferase expression suppression without causing any
toxic eﬀect (Fig. 11). Therefore, to achieve similar gene silencing
eﬃciency with the polyplex systems, larger amounts of siRNA and
polymer are needed to form the complexes. However, this may
potentially exacerbate the toxicity problem.13 Themain reason for
better transfection eﬃciencies of the MCS at the same siRNA
doses is the presence of cleavable disulde bonds in their
structure which are broken by the glutathione existing in the
cytoplasm facilitating the siRNA release, hence, increasing its
luciferase activity within the cell.19,43,63On the contrary, the strong
electrostatic interactions between the polymer and siRNA in the
polyplex systems prevent the eﬃcient release of siRNA.17 In
Fig. 10 Cell viability of AuNP–siRNA–Polymer A MCS treated SKOV3 cells. Applied MCS dose (based on AuNP amount): 5 nM per well. Applied
siRNA dose: 100 nM per well. Applied polymer dose: 500 nM per well. Initial SKOV3 cell density: 1.5  104 cell per well. Controls: AuNP–PEG,
AuNP–PEG–SPDP, uncoated AuNP–siRNA (without Polymer A), Polymer A alone, control SKOV3 cell. Incubation time: 24 h. AuNP–siRNA–
Polymer A MCS prepared with diﬀerent polymer amounts; the layers of this multicomponent system (AuNP–PEG, AuNP–PEG–SPDP and AuNP–
siRNA) and Polymer A alone did not cause signiﬁcantly diﬀerent cell viabilities compared with the SKOV3 cell alone (p > 0.05).
Fig. 11 Luciferase suppression of prepared AuNP–siRNA–Polymer A MCS. Applied MCS dose (based on AuNP amount): 5, 2.5, 1.25 nM per well.
Applied siRNA dose: 25, 50, 100 nM per well. Initial SKOV3 cell density: 1.5  104 cell per well. Controls: AuNP–Polymer A (without siRNA),
uncoated AuNP–siRNA (without Polymer A), commercial Lipofectamine RNAiMax siRNA transfection reagent, Polymer A alone, SKOV3 cell.
Incubation time: 24 h. (a–c) Represent doses of AuNP–siRNA–Polymer A MCS which caused signiﬁcant diﬀerence in luciferase expression
(p < 0.05) for AuNP/Polymer ratios of 1/10, 1/50 and 1/100, respectively. (d–f) Represent the signiﬁcant diﬀerence in luciferase expression
suppression of MCSs with diﬀerent AuNP/Polymer ratio (p < 0.05). (g) Represents the diﬀerence between commercial Lipofectamine RNAiMax
transfection reagent and preparedMCSs. Only theMCS with AuNP/Polymer ratio of 1/100 and dose of 5 nM signiﬁcantly decreased the luciferase
expression (p < 0.05) compared to RNAiMax while the ones with AuNP/Polymer ratios of 1/10 and 1/50 managed to keep the luciferase
expression in the same level as commercial RNAiMax at dose of 5 nM. * Compared to AuNP–siRNA–Polymer A MCS, AuNP/Polymer A MCS
showed signiﬁcantly lower luciferase expression suppression (p < 0.05) at all AuNP/Polymer ratios and doses applied. ** Uncoated AuNP/siRNA
MCS, at all doses applied or Polymer A alone or control SKOV3 cell showed signiﬁcantly lower luciferase expression suppression than AuNP–
siRNA–Polymer A MCS.
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addition, the construction of multicomponent systems is also
potentially sterically more advantageous by allowing more free
blocks of both Pluronic F127 and PDEAEM on the surface as
compared to the polyplexes in which part of the blocks are
embedded in the structure. The conguration of the polymer on
the MCS surface, which stimulates the eﬀect of thermoreversible
micellization capability of hydrophobic PPO block, as well as
their relatively smaller size and zeta potential valuesmay possibly
enhance the cellular entry of the MSC as compared to the poly-
plexes, leading to higher transfection eﬃciency. Another reason
for higher luciferase suppression of theMCSs was their capability
of escaping from endosome and distributing in cytoplasm more
eﬃciently than the polyplexes (Fig. 3 and 9). In order to prove that
the developed MCSs are eﬃcient siRNA delivery systems, their
performances were compared with the commercial siRNA
transfection reagent (Lipofectamine RNAiMax). The results in
Fig. 11 showed that the developed MCS (AuNP/Polymer ratio:
1/100 and applied dose 5 nM) provided15% greater decrease in
luciferase expression compared to the commercial RNAiMax
siRNA transfection reagent. This result also proves the eﬃciency
and superiority of the developed systems.
The MCSs prepared by Polymer C showed severe toxicity as
indicated in Fig. S11.† The toxic eﬀect of Polymer C led to
conicting results in luciferase activity of siRNA about the real
source of luciferase suppression (due to pure siRNA activity or
toxicity of Polymer C). The transfection eﬃciencies of the MCS
fabricated with polymer C were found to be similar to those of
the AuNP–siRNA–polymer A MCS (Fig. S12†). On the other
hand, when toxicity prole in Fig. S11† is considered, it
becomes clear that most of the decrease in the luciferase
expression is not due to siRNA activity but because of the cell
death resulting from the toxic eﬀect of the MCS. This toxic eﬀect
could be due to the massive cationic nature of Polymer C
involving longer PDEAEM chains. The result clearly demon-
strated that the length of the cationic blocks and the ratio
between the cationic and non-cationic blocks in the pentablock
copolymers has a signicant inuence on the toxicity of the
MCS as it determines the amount of positively charged groups,
hence, the degree of interaction with the cell membrane. This
allows us to easily tune the cytotoxicity of the pentablock
copolymers by varying the lengths of the cationic blocks and the
ratio between the cationic and non-ionic blocks.
4 Conclusion
We have developed and demonstrated the eﬃcacy of PDEAEM–
PluronicF127–PDEAEM pentablock copolymer-based multicom-
ponent for siRNA delivery. The potential of the copolymer was
evaluated in the development of the polyplex systems formed
through the direct electrostatic interactions with siRNA and
multicomponent systems prepared by coating the PEG modied
AuNPs with siRNA through the cleavable disulde bonds and
subsequently with the pentablock copolymers by electrostatic
interactions. The results indicated that both type of delivery
systems managed to protect siRNA from external eﬀects and
maintain the system stability (in terms of size and zeta potential)
in serum supplemented cell culture media. The presence of
hydrophobic PPO blocks in both systems enhanced the ther-
moresponsive micellization and facilitated the cellular entry
while the cationic pH responsive PDEAEM block provided the
pH buﬀering in the acidic media of endosome and enhanced the
endosomal escape, especially in the multicomponent systems. It
was noticed that the nature and form of polymer attachment to
siRNA and its conformation upon the attachment is critical for
both of the systems in terms of their cell uptake, endosomal
escape and transfection eﬃciency performances. The surface
attachment of polymers to siRNA inMCSs reveals the advantages
of each block, whereas, the possible embedding of the functional
blocks inside the polyplex matrix restricts their properties.
Because of these arguments, endosomal escape capabilities of
MCSs were seen to be better than that of the polyplex systems
alone. These features of MCSs contributed to their higher
transfection eﬃciencies compared to polyplexes. To achieve the
same level of luciferase expression suppression, the siRNA
loading required in the multicomponent system is lower than
that in the polyplex system. Contrary to the case of polyplex
systems requiring high polymer amount for complexation with
siRNA, this situation brings about lower amounts of polymer use
in MCSs to form nontoxic systems. Besides the polymer
amounts, it was noted that the manipulation of molecular
weight through the ratios or length of each block can be used to
tune the toxicity of the polymers. Moreover, the high amount of
polymers in polyplex systems forms strong electrostatic
complexes avoiding the eﬃcient release and therefore activity of
siRNA in cytoplasm. On the other hand, the cleavable disulde
bonds in MCS structure promoting siRNA release in the cyto-
plasm is one of the key factors enhancing their transfection
eﬃciency. The overall results suggest that the advantage of each
block in the pentablock copolymer is highlighted better in the
multicomponent conjugate system. When the performance of
the developed systems was compared with that of commercial
siRNA transfection agent RNAiMax, it was noted that the trans-
fection eﬃciency with the MCS was 15% higher than the
commercial product while the eﬃcacy of polyplexes alone were
similar to the RNAiMax, indicating the potential of the polymer-
based MCS systems. It can be concluded that the responsive
pentablock copolymers are promising vectors to deliver siRNA,
especially when used in multicomponent systems.
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